Anthony Letai, Director of the National Cancer Institute, shared a post on X:
“Progress in glioblastoma – an aggressive brain cancer, has been limited for decades. New NCI-funded work shows how the tumor microenvironment can weaken the body’s immune response, suggesting a new approach for making immunotherapy work better.”
Boosting the immune response to brain cancer
Other articles featuring Anthony Letai on OncoDaily.